**Core Concept:** Prevention of neonatal infection due to Hepatitis B virus (HBV) transmission from an infected mother to the baby during childbirth.

**Why the Correct Answer is Right:** Hepatitis B vaccine, Hepatitis B immunoglobulin (HBIG), and Universal Neonatal Hepatitis B vaccination are indicated in this scenario to prevent neonatal infection. HBV transmission occurs through direct contact with infected bodily fluids, such as blood. Since the mother is HBsAg positive, she is considered a "high-risk" case. Administering the vaccine and HBIG to the baby within 12 hours of birth can significantly reduce the risk of neonatal HBV infection.

Hepatitis B immunoglobulin (HBIG) is a concentrated serum product containing antibodies against HBV surface antigen (HBsAg), which neutralizes the virus in the newborn's bloodstream, preventing viral replication. The vaccine, on the other hand, stimulates the baby's immune system to produce its own antibodies against HBsAg, providing long-term immunity.

**Why Each Wrong Option is Incorrect:**

A. Vaccination alone is not enough to prevent neonatal HBV infection without HBIG administration. Vaccine-induced antibodies need a "boost" from HBIG to be effective.

B. HBIG injection alone is insufficient to protect the baby from HBV infection without vaccination.

C. Waiting for the baby to be born before administering any intervention is not a practical or effective strategy to prevent neonatal HBV transmission.

D. Administering only Hepatitis B vaccine after the baby is born is not effective enough to prevent neonatal infection without immediate postnatal administration of HBIG.

**Clinical Pearl:** Timing is crucial when administering these preventive measures for neonatal HBV infection. Ensuring that both HBIG and Hepatitis B vaccine are given within 12 hours of birth significantly increases the effectiveness of preventing perinatal HBV transmission.